Palmitoyl Oligopeptide
Elastin-derived signal peptide that stimulates dermal matrix renewal and skin elasticity through matrikine signaling.
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Suggested dose
0.002 % – 10 ppm
Compound profile
Scientific & efficacy data
Cosmetic
Peptide profile
Limited human trials
Palmitoyl Oligopeptide
Under 10 ppm (<0.001%) in finished product · Once daily
Molecular formula
C36H63N5O7 (hexapeptide-12 variant)
- Mol. weight
- 694.9 Da (approximate for palmitoylated hexapeptide)
- CAS number
- 171263-26-6
- PubChem
- Not individually indexed (component of cosmetic formulations)
- Developed · 2003
- Lipotec S.A. research team
Lipotec S.A. (Lubrizol Corporation)
Amino acid sequence
Pal-VGVAPG (Palmitoyl-Val-Gly-Val-Ala-Pro-Gly) — elastin-derived matrikine sequenceCollagen Stimulation
Acts as a matrikine signal peptide to upregulate collagen type I, III, and IV synthesis in dermal fibroblasts through TGF-β pathway activation.
Skin Elasticity
Enhances elastin production and strengthens the extracellular matrix framework, improving skin resilience and reducing sagging.
Skin Hydration
Stimulates hyaluronic acid synthesis and strengthens the skin barrier to reduce transepidermal water loss and improve moisture retention.
Dosing
How much do I take?
0.002 % – 10 ppm
0.002 % – 10 ppm
Covers all 2 documented dose levels · timing · dose-adjustment guidance.
Suitability
Is this right for me?
Best for individuals seeking collagen and elastin stimulation through topical peptides & those with age-related loss of skin firmness and elasticity
Best for
Individuals seeking collagen and elastin stimulation through topical peptides
Palmitoyl Oligopeptide is particularly well-suited for individuals focused on individuals seeking collagen and elastin stimulation through topical peptides. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Those with age-related loss of skin firmness and elasticity
Palmitoyl Oligopeptide is particularly well-suited for individuals focused on those with age-related loss of skin firmness and elasticity. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
People looking for gentle anti-aging actives suitable for sensitive skin
Palmitoyl Oligopeptide is particularly well-suited for individuals focused on people looking for gentle anti-aging actives suitable for sensitive skin. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Users wanting to complement retinoid or vitamin C regimens with peptide support
Palmitoyl Oligopeptide is particularly well-suited for individuals focused on users wanting to complement retinoid or vitamin c regimens with peptide support. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Consider alternatives if
Do not use if
Use with caution if
Not sure?
Compare Palmitoyl Oligopeptide with similar peptides to find the best fit for your goals.
Administration
How do I use it?
Topical
Route
Palmitoyl Oligopeptide is administered Topical—no injection required
Best sites
Covers reconstitution · step-by-step technique · storage · a sample daily schedule.
Safety
Is it safe?
4 common side effects · 2 serious
Palmitoyl oligopeptide has GRAS-equivalent status for cosmetic use with no serious adverse events in safety testing up to 5% w/w in topical formulations.
Mild skin irritation reported in <3% of subjects at high concentrations (irritation index 0-1 on 0-10 scale). No dermal penetration beyond stratum corneum in Franz diffusion cell studies. Long-term use data spans 15+ years of cosmetic industry application with no systemic toxicity.
Cosmetic safety database (CosIng) documentation confirms mechanism through collagen synthesis stimulation (procollagen type I ELISA) and MMP inhibition preventing collagen breakdown. In vitro elasticity measurements using mechanical testing show 20-30% elasticity improvements over 8 weeks.
Dermatological testing per ISO 10993 confirms biocompatibility; histopathology shows no irritation at concentrations up to 3%.
Common side effects · experienced by some users
Transient Dryness
Rare mild dryness during initial use, typically resolving within the first week of application.
Management: Apply over a hydrating serum or follow with a moisturizer. Reduce application frequency if persistent.
Mild Tingling
Slight tingling sensation upon first application in some sensitive individuals, generally benign and transient.
Management: Normal sensory response. If uncomfortable, dilute product or reduce concentration.
Product Interaction Sensitivity
Potential for mild irritation when layered with strong active acids or retinoids in the same application.
Management: Separate acid-based products to different times of day. Apply peptide serum first, then other actives after absorption.
Minimal Erythema
Very rare mild redness at application site in highly reactive skin types.
Management: Reduce frequency to once daily. Patch test on inner arm before facial application.
Less common
These typically resolve with continued use or dose adjustment.
Stop and seek help if
- Severe or worsening side effects that don't improve with dose adjustment or supportive care
- Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
- Your healthcare provider recommends discontinuation based on your clinical response
- Development of any new medical condition that may be contraindicated with Palmitoyl Oligopeptide
- Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
- Abnormal lab results or clinical markers that suggest adverse effects
Palmitoyl Oligopeptide should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
With other peptides
- Safe:Hyaluronic Acid — May be used together under medical guidance.
- Safe:Retinol — May be used together under medical guidance.
- Safe:Vitamin C (stabilized forms) — May be used together under medical guidance.
With medications
- Caution:Benzoyl Peroxide — Use with caution—discuss with your healthcare provider.
- Caution:High-concentration AHAs (>15%) — Use with caution—discuss with your healthcare provider.
- Caution:Strong oxidizing agents — Use with caution—discuss with your healthcare provider.
With supplements
- Safe:Multivitamins — Generally safe to take alongside Palmitoyl Oligopeptide. Space doses apart if taking oral formulations to ensure optimal absorption.
- Safe:Electrolyte supplements — Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.
Effectiveness
How do I know it's working?
Limited human trials · first signs weeks 1-4
Evidence level
Limited human trials
Regulatory status
Research compound
Onset of effects
Moderate
(1-2 weeks)
How it works
Palmitoyl-oligopeptide is a signal peptide coupled with a fatty acid (palmitic acid) that tells your skin cells to produce more collagen and elastin.
The fatty acid helps it penetrate the skin barrier, so it can reach deeper skin cells. This stimulates your skin's natural structural proteins, improving firmness, elasticity, and reducing signs of aging.
The deeper mechanism
Palmitoyl-oligopeptide is a palmitoyl-coupled signal peptide designed to improve skin penetration through increased lipophilicity while activating fibroblast-mediated collagen synthesis.
The palmitic acid moiety increases skin barrier penetration and cellular uptake, allowing the oligopeptide sequence to interact with cell surface receptors (potentially TGF-β-related signaling) or intracellular signaling pathways that upregulate type I and III collagen gene expression.
Palmitoyl conjugation is a biotechnological modification that mimics naturally occurring lipidated peptides, enhancing dermal bioavailability compared to hydrophilic parent sequences.
Signal peptide mechanisms activate fibroblast transcription factors (including NF-κB-dependent pathways) that increase ECM protein synthesis including hyaluronic acid production, improving hydration and dermal density.
What to expect
Weeks 1-4
What you might notice
- Skin barrier strengthening and initial hydration improvements
- Matrikine signaling activates fibroblast collagen and elastin gene expression
- Subtle improvements in skin texture and moisture retention may be noticed
What's normal
- Full integration of Palmitoyl Oligopeptide into physiological systems is established
- Long-term Palmitoyl Oligopeptide response remains personalized to your physiology
- Palmitoyl Oligopeptide tolerance is well-maintained with consistent dosing
What's next
- Maintain your established Palmitoyl Oligopeptide protocol for sustained benefits
- Continue periodic monitoring to confirm Palmitoyl Oligopeptide efficacy
- Review comprehensive Palmitoyl Oligopeptide response with your provider
Weeks 4-8
What you might notice
- Measurable firmness improvement begins
- New collagen and elastin synthesis becomes apparent
- Fine lines appear softer
- Skin texture refinement progresses with continued twice-daily application
What's normal
- Palmitoyl Oligopeptide is now achieving steady-state pharmacokinetics
- Measurable changes aligned with Palmitoyl Oligopeptide's mechanism may appear
- Initial adjustment effects typically resolve by this point
What's next
- Maintain Palmitoyl Oligopeptide dosing exactly as established
- Track progress toward intended outcomes in detail
- Review lab work or biomarker changes with your healthcare team
Weeks 8-12+
What you might notice
- Optimal results achieved
- Significant wrinkle reduction documented in clinical studies
- Improved elasticity, firmness, and overall skin tone
- Continued use maintains and builds upon improvements
What's normal
- Full therapeutic effects of Palmitoyl Oligopeptide are well-characterized at this point
- Maintenance of Palmitoyl Oligopeptide's therapeutic effects is typical
- Tolerance patterns with Palmitoyl Oligopeptide are generally stable over months
What's next
- Comprehensive assessment of Palmitoyl Oligopeptide efficacy should be conducted
- Discuss long-term continuation, cycling, or protocol modifications
- Continue regular monitoring of relevant biomarkers or symptoms
Signs it's working
Treatment Response
- Improvement in the primary symptoms or condition being treated
- Positive changes in relevant lab values or clinical markers
- Consistent, stable response to Palmitoyl Oligopeptide over time
- Reduction in symptom frequency or severity
General Well-being
- Improved energy levels and daily functioning
- Better quality of life related to the treated condition
- Manageable or absent side effects indicating good tolerance
- Positive feedback from healthcare provider during check-ups
Not seeing results? Common reasons
- Not at therapeutic dose yet—initial doses are for building tolerance, not maximum effect
- Insufficient time at target dose—most compounds need several weeks to show full benefits
- Inconsistent dosing schedule—regular, consistent use is crucial for optimal results
- Individual variation in response—genetics, metabolism, and other factors affect outcomes
- Underlying conditions or medications interfering with absorption or effectiveness
- Improper storage leading to degraded product—always verify proper storage conditions
Key research
Questions
Frequently asked
How is Palmitoyl Oligopeptide different from Palmitoyl Pentapeptide-4 (Matrixyl)?
Palmitoyl Oligopeptide (Hexapeptide-12) uses a VGVAPG sequence derived from elastin, while Palmitoyl Pentapeptide-4 (Matrixyl) uses a KTTKS sequence derived from procollagen. Both are matrikine signal peptides but target slightly different aspects of ECM production. They are complementary and often found together in advanced formulations.
Can Palmitoyl Oligopeptide be used with retinol?
Yes. Palmitoyl Oligopeptide and retinol work through complementary mechanisms for collagen stimulation. Apply the peptide serum first, allow absorption, then apply retinol. For sensitive skin, consider using peptide in the morning and retinol at night.
How long until I see results?
Initial hydration improvements may be noticeable within 2-4 weeks. Measurable wrinkle reduction and firmness improvements typically require 8-12 weeks of consistent twice-daily application. Results continue to build with ongoing use.
Is Palmitoyl Oligopeptide safe for sensitive skin?
Yes. Palmitoyl Oligopeptide has an excellent safety profile with minimal irritation potential. It is well-tolerated across skin types including sensitive skin. The CIR (Cosmetic Ingredient Review) panel has affirmed its safety for cosmetic use.
What is the ideal concentration for best results?
Clinical evidence supports concentrations of 0.3-1% in finished products for meaningful anti-aging benefits. Higher concentrations (1-3%) may provide enhanced effects in intensive treatment formulations. Even very low concentrations (0.003%) show measurable biological activity in laboratory studies.
Further reading
History & related research
History · since 1990
The chemical messenger that tells your skin to stay young and firm
A cosmetic peptide engineered by attaching a fatty acid chain to a six-amino-acid chain. It signals skin cells to produce more collagen and hyaluronic acid, the two substances that keep skin firm, smooth, and hydrated.
Read the full history of Palmitoyl OligopeptideReady for the protocol?
Every dosing tier, administration route, timing note, and dose-adjustment rule for Palmitoyl Oligopeptide, on one page.